iproniazid has been researched along with Atherosclerotic Parkinsonism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dandiya, PC | 1 |
| Bhargava, LP | 1 |
| Hassler, R | 1 |
| Bak, IJ | 1 |
2 other studies available for iproniazid and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine | 1968 |
[Submicroscopic catecholamine stores as sites of attack of the psychopharmaca, reserpine and monoamine oxidase inhibitors].
Topics: Animals; Catecholamines; Caudate Nucleus; Dopamine Antagonists; Epinephrine; Extrapyramidal Tracts; | 1966 |